Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
45.38 USD | +0.48% | +8.04% | -0.82% |
May. 14 | Transcript : Belite Bio, Inc, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Belite Bio, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 20
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 18-03-26 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 20-10-31 |
Nathan L. Mata
CTO | Chief Tech/Sci/R&D Officer | 58 | 21-10-31 |
Jennifer Wu
IRC | Investor Relations Contact | - | - |
Ching Chen Chiu
PRN | Corporate Officer/Principal | 55 | 21-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 22-03-31 | |
Yi Ta Lue
BRD | Director/Board Member | 47 | 22-03-31 |
John Longo
BRD | Director/Board Member | 55 | 22-03-31 |
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 18-03-26 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 20-10-31 |
Hung Wei Chen
BRD | Director/Board Member | 43 | 21-10-31 |
Wan Shan Chen
BRD | Director/Board Member | 38 | 21-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,794,433 | 29,496,489 ( 99.00 %) | 0 | 49.50 % |
Stock B | 1 | 29,794,433 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.82% | 1.32B | |
+41.53% | 54.04B | |
+43.57% | 41.96B | |
-1.14% | 41.92B | |
-7.59% | 28.35B | |
+12.31% | 26.35B | |
-22.39% | 19B | |
+7.92% | 13B | |
+29.16% | 12.28B | |
+25.02% | 12.19B |
- Stock Market
- Equities
- BLTE Stock
- Company Belite Bio, Inc